Literature DB >> 28644007

Cyclotides as Tools in Chemical Biology.

Simon J de Veer1, Joachim Weidmann1, David J Craik1.   

Abstract

Among the various molecules that plants produce for defense against pests and pathogens, cyclotides stand out as exceptionally stable and structurally unique. These ribosomally synthesized peptides are around 30 amino acids in size, and are stabilized by a head-to-tail cyclic peptide backbone and three disulfide bonds that form a cystine knot. They occur in certain plants of the Rubiaceae, Violaceae, Cucurbitaceae, Fabaceae, and Solanaceae families, with an individual plant producing up to hundreds of different cyclotides. Aside from being exploitable as crop protection agents based on their natural pesticidal activities, cyclotides are amenable to repurposing by chemists for use as drug leads or as tools in chemical biology. Their macrocyclic peptide backbone and knotted arrangement of three disulfide bonds engenders cyclotides with resistance to proteolytic degradation, high temperatures, and chemical chaotropes. Furthermore, their small size makes them accessible to synthesis using solid-phase peptide chemistry and so non-natural cyclotides can be designed and synthesized for a variety of applications. Our focus here is on cyclotides as tools in chemical biology, and there are four main areas of application that have appeared in the literature so far: (i) cyclotides as probes of membrane binding; (ii) cyclotides as probes of biosynthetic pathways for peptide cyclization; (iii) cyclotides as probes of protease specificity and function; and (iv) cyclotides as probes of receptor binding and specificity, with the potential for them to be developed as drug leads. The main methods used in these studies include solid-phase peptide chemistry for synthesis and NMR spectroscopy for structural characterization, as well as a wide range of biochemical and biophysical techniques for probing intermolecular interactions. In addition, cyclotides have been examined in diverse biological assays, ranging from enzyme inhibition to cell penetration, intracellular targeting and cytotoxicity. The main finding to have emerged from studies over the past decade is that cyclotides are exceptionally stable under a variety of conditions (in assay buffers, biological fluids, membranes, and recombinant expression systems). Furthermore, they are structurally very well-defined and amenable to sequence substitutions that can introduce new desired biological activities, generally without compromising their exceptional stability. Both features contribute to their use as peptide-based frameworks in drug design. Finally, they occupy a size niche between traditional small-molecule drugs (<500 Da in molecular weight) and protein-based biologics (>5000 Da) and thus can probe receptors, membranes, and protein-protein interactions in different ways to what is possible with either small molecules or biologics. Overall, cyclotides are an exciting class of peptides that have great potential as ultrastable chemical biology probes in a variety of applications. They have the advantage of specificity (typical of proteins) combined with the synthetic accessibility of small molecules.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28644007     DOI: 10.1021/acs.accounts.7b00157

Source DB:  PubMed          Journal:  Acc Chem Res        ISSN: 0001-4842            Impact factor:   22.384


  11 in total

Review 1.  Occurrence, function, and biosynthesis of mycofactocin.

Authors:  Richard Ayikpoe; Vishnu Govindarajan; John A Latham
Journal:  Appl Microbiol Biotechnol       Date:  2019-02-18       Impact factor: 4.813

2.  Gas-Phase Sequencing of Cyclotides: Introduction of Selective Ring Opening at Dehydroalanine via Ion/Ion Reaction.

Authors:  David J Foreman; Nicole C Parsley; John T Lawler; Uma K Aryal; Leslie M Hicks; Scott A McLuckey
Journal:  Anal Chem       Date:  2019-12-03       Impact factor: 6.986

3.  Assessing the Flexibility of the Prochlorosin 2.8 Scaffold for Bioengineering Applications.

Authors:  Julian D Hegemann; Silvia C Bobeica; Mark C Walker; Ian R Bothwell; Wilfred A van der Donk
Journal:  ACS Synth Biol       Date:  2019-05-08       Impact factor: 5.110

4.  Programmable protein topology via SpyCatcher-SpyTag chemistry in one-pot cell-free expression system.

Authors:  Qingning Ye; Xiaomei Lin; Ting Wang; Yuntao Cui; Hao Jiang; Yuan Lu
Journal:  Protein Sci       Date:  2022-06       Impact factor: 6.993

5.  MftD Catalyzes the Formation of a Biologically Active Redox Center in the Biosynthesis of the Ribosomally Synthesized and Post-translationally Modified Redox Cofactor Mycofactocin.

Authors:  Richard S Ayikpoe; John A Latham
Journal:  J Am Chem Soc       Date:  2019-08-15       Impact factor: 15.419

6.  Coupling Plant-Derived Cyclotides to Metal Surfaces: An Antibacterial and Antibiofilm Study.

Authors:  Pan Cao; Ying Yang; Fidelia Ijeoma Uche; Sarah Ruth Hart; Wen-Wu Li; Chengqing Yuan
Journal:  Int J Mol Sci       Date:  2018-03-09       Impact factor: 5.923

7.  Chemical Synthesis and Functional Analysis of VarvA Cyclotide.

Authors:  Claudio A Álvarez; Paula A Santana; Omar Luna; Constanza Cárdenas; Fernando Albericio; María S Romero; Fanny Guzmán
Journal:  Molecules       Date:  2018-04-19       Impact factor: 4.411

Review 8.  Modulating Protein-Protein Interactions by Cyclic and Macrocyclic Peptides. Prominent Strategies and Examples.

Authors:  Rosario González-Muñiz; María Ángeles Bonache; María Jesús Pérez de Vega
Journal:  Molecules       Date:  2021-01-16       Impact factor: 4.411

9.  Importance of the Cyclic Cystine Knot Structural Motif for Immunosuppressive Effects of Cyclotides.

Authors:  Roland Hellinger; Edin Muratspahić; Seema Devi; Johannes Koehbach; Mina Vasileva; Peta J Harvey; David J Craik; Carsten Gründemann; Christian W Gruber
Journal:  ACS Chem Biol       Date:  2021-09-30       Impact factor: 4.634

10.  Tryptophan-Containing Cyclic Decapeptides with Activity against Plant Pathogenic Bacteria.

Authors:  Cristina Camó; Maria Torné; Emili Besalú; Cristina Rosés; Anna D Cirac; Gemma Moiset; Esther Badosa; Eduard Bardají; Emilio Montesinos; Marta Planas; Lidia Feliu
Journal:  Molecules       Date:  2017-10-26       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.